TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 28 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $19,631,000 | +567.0% | 1,117,927 | +268.5% | 0.00% | – |
Q2 2021 | $2,943,000 | -42.7% | 303,392 | -36.5% | 0.00% | – |
Q1 2021 | $5,132,000 | -80.6% | 477,801 | -73.5% | 0.00% | -100.0% |
Q4 2020 | $26,510,000 | +200.2% | 1,802,212 | +190.0% | 0.00% | +100.0% |
Q3 2020 | $8,832,000 | +143.5% | 621,520 | +38.6% | 0.00% | 0.0% |
Q2 2020 | $3,627,000 | +352.2% | 448,316 | +125.8% | 0.00% | – |
Q1 2020 | $802,000 | +1133.8% | 198,586 | +101.3% | 0.00% | – |
Q1 2019 | $65,000 | -68.0% | 98,673 | +249.9% | 0.00% | – |
Q1 2018 | $203,000 | -51.7% | 28,200 | -51.3% | 0.00% | – |
Q4 2017 | $420,000 | +12.9% | 57,900 | +130.0% | 0.00% | – |
Q3 2016 | $372,000 | – | 25,170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |